Search for: [Abstract = "dilutions were used. Differences between transcripts level during therapy were presented as a ratio of BCR\-ABL to ABL copy number, and correlates to clinical image of the patients. The sensitivities of the tests were oscillated about 104 – 105. RQ\-PCR method is very efficient and accurate assay to monitor BCR\-ABL expression in CML patients treated with Imatinib and another tyrosine kinase inhibitors. RQ\-PCR is reliable and sensitive method for monitoring CML patients after therapy. This is also convenient, robust and routine method for monitoring of minimal residual disease in CML patients. Quantifications of the level of residual disease using RQ\-PCR has also therapeutic implications for the follow\-up of therapeutic interventions for relapse."]

Number of results: 1